An official at the 3rd Middle East Molecular Biology Congress & Exhibition 2016.
Qatar University launched yesterday the 3rd Middle East Molecular Biology Congress & Exhibition 2016 with an opening ceremony attended by QU officials, faculty, students and staff, and experts and researchers in molecular biology.
The event (November 14-18), the first of its kind in the region, is a collaboration between QU and Middle East Molecular Biology Sources (MEMBS), and is sponsored by Hamad Medical Corporation (HMC), Qatar Biobank for Medical Research, Qatar Biomedical Research Institute (QBRI), Qatar Genome Programme, Qatar Tourism Authority (QTA), Sidra Medical and Research Center, and Weill Cornell Medical College in Qatar (WCMC-Q). Its aim is to provide a platform for representatives of the academic and industrial communities to interact and promote the translation of research into therapy.
The forum brings together around 500 leading biologists and biomedical engineers, including professors and their trainees from the academic, clinical and pharmaceutical fields to showcase their research, highlight the use of emerging technologies, and encourage interactions and new interdisciplinary collaborations.
QU President Dr Hassan Al Derham said: “QU is proud to host the 3rd Middle East Molecular Biology Congress & Exhibition 2016, which brings together leading experts to showcase the latest technologies in molecular biology. During the past years, molecular biology has made a progress in key areas such as genome sciences, cell therapy, cancer treatment, and diabetes, which has a positive impact on human life and health.
